Pharmaceutical Errors: When Drugs Cause Dangerous Effects
Advancements in science and technology have helped the pharmaceutical industry to create better solutions to the most pressing medical issues. However, there are times when these solutions lead to unforeseen effects. Defective pharmaceutical products make up a large number of all product liability lawsuits filed in America. It’s an unfortunate fact that there are some drugs and medications which lead to effects opposite to what they were originally intended for.
The website of the National Injury Law Center found that pharmaceutical errors and other similar issues are usually caused by several factors. One of these involves the Food and Drug Administration (FDA), which is the agency tasked to examine new medical products before approving them for public use. Sometimes, the most scrupulous testing process can miss certain problems and side effects. This is especially true for cases when physical manifestation of certain side effects take time.
However, pharmaceutical companies are typically the ones most accountable for controversies involving new medical products. Plenty of companies market their products for uses that aren’t approved by the FDA. Among such controversial cases involve AlloDerm, which is a skin grafting tissue manufactured by LifeCell Corporation.
Medical issues involving damage to skin cells are typically addressed through a surgical procedure called skin grafting. In order to repair this damage, surgeons make use of skin from another part of the patient’s body. LifeCell was able to introduce an alternative around the year 1992. Instead of harvesting skin tissue from the patient’s body, doctors can make use of a biologic tissue processed from donated human tissue. This alternative was primarily intended for skin grafting procedures done on burn victims. However, LifeCell has been marketing the use of AlloDerm for breast reconstruction and hernia repair.
Unfortunately, AlloDerm has reportedly caused several issues for patients who have undergone such procedures. A 2010 study in the Journal of Plastic Surgery, which was conducted by doctors from the University of Cincinnati and Harvard Medical School, looked into the infectious complications caused by the product during breast reconstruction surgeries. Another research published in the medical journal Springer Link, found that hernia repairs using AlloDerm led to a complication rate of 24 percent. . Patients typically complain of complications involving infections, perforations, and abscesses. Considering these grave consequences, it’s no wonder that filing an AlloDerm lawsuit is the common route that patients take to find just compensation. People considering this sort of action often contact defective pharmaceutical lawyers for guidance.